S&P 500   5,011.12 (-0.22%)
DOW   37,775.38 (+0.06%)
QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
S&P 500   5,011.12 (-0.22%)
DOW   37,775.38 (+0.06%)
QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
S&P 500   5,011.12 (-0.22%)
DOW   37,775.38 (+0.06%)
QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
S&P 500   5,011.12 (-0.22%)
DOW   37,775.38 (+0.06%)
QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)

Scotts Miracle-Gro Hits Bottom, Reversal In Play

→ The Next Nvidia? (From InvestorPlace) (Ad)

Scotts Miracle-Gro Hits Bottom, Reversal In Play

Key Points

  • Scotts Miracle-Gro hit a bottom, and a reversal is in play. 
  • Results and plans to save more than $185 million annually are driving the move. 
  • There is risk in the outlook but the 3.65% dividend helps to offset it. 
  • 5 stocks we like better than Scotts Miracle-Gro

Those who’ve watched the Scotts Miracle-Gro NYSE: SMG saga unfold over the last few years have seen it bottom, gear up for growth, expand into the cannabis equipment market, get boosted by the pandemic, and then see it all come crashing down. The bursting COVID bubble was compounded by issues within the cannabis market that suggest it was played out before it was opened.

All the hype for growth was overblown and Scotts Miracle-Gro, like so many others, got caught up in it. The takeaway today is that it is 4 going on 5 years since all this began and dark times appear to be over. The price action hit a bottom in late 2022, that bottom was confirmed at the end of the year/first of the new year and now a reversal is in play. 

Scotts Miracle-Gro Rebound Is In Play 

A question investors need to ask, however, is if this reversal will lead the stock higher or if it is trapped in a trading range. Reversals all too often take a market from down to sideways before the next uptrend can start. Vee-bottoms are rare, and it does not look like Scotts Miracle-Gro is any different. While the bottom is in, there are still hurdles to cross before a real rally can take hold. 

Among those is a return to profitability, specifically in the Hawthorne (cannabis equipment) segment, which is doing so poorly. The good news is that core business is helping to carry the company, sustain capital returns for shareholders and drive profits for the business on an annualized basis.

The Q1 loss is a bummer but not unexpected given the season; Q1 is always the weakest and usually comes with a loss. Hawthorne made it worse, for sure, but that situation is on the med, and the company’s balance sheet is still in good shape. 

“Record December shipments in the U.S. Consumer business contributed to a strong early season buildout demonstrating confidence in the lawn and garden season. Our focus now is on early consumer engagement, and POS lifts in coordination with retail partners. While Hawthorne continues to manage through a challenging market, we are committed to returning the business to profitability by the end of this fiscal year. Overall, we are in a stable place and are well prepared to execute our full-year plan.”


What is driving the rebound in share prices? Results, operational execution and an outlook for business to improve. In regard to results, the FQ1 revenue and earnings are down versus last year, but both figures are better than expected. The revenue was bolstered by an 8% increase in US consumer sales, the primary business category.

This is great news in light of the forecast for Hawthorne, which suggests profitability could come for it sometime in the now-ish to Q4 period. The company’s aptly-named Project Springboard has it on track to achieve greater than the original $185 million in annual savings, which should get that segment back in the green and boost overall company profitability. 

Scotts Miracle-Gro Guidance Is Mixed 

Scotts Miracle-Gro is giving mixed guidance but guidance consistent with the expectations. The company forecasts a 20% to 30% decline in Hawthorne revenue, offset by growth in the core US consumer business. The gross margin will also contract by low single digits, but one-off costs related to restructuring and growth repositioning are not expected to recur. That will result in better operating margins and EPS growth. 

Turning to the chart, SMG is up more than 4.5% in the wake of the news and now trading firmly above the 150-day EMA. The move suggests a shift in the tide that should keep a firm floor in the price. The near-term outlook has the price action moving up to the $90 level, if it can get above there, a fuller reversal may unfold. If not, this stock may remain range bound at or near current levels until more signs of improvement materialize. Until then, the company is paying a 3.65% dividend which is only 65% of the full-year earnings expectations. 

It’s A Miracle! Scotts Miracle-Gro Hits Bottom

→ The Next Nvidia? (From InvestorPlace) (Ad)

Should you invest $1,000 in Scotts Miracle-Gro right now?

Before you consider Scotts Miracle-Gro, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Scotts Miracle-Gro wasn't on the list.

While Scotts Miracle-Gro currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Scotts Miracle-Gro (SMG)
2.9872 of 5 stars
$67.96+0.4%3.88%-9.65Hold$70.00
Compare These Stocks  Add These Stocks to My Watchlist 

Thomas Hughes

About Thomas Hughes

  • tmhughes.writeon@gmail.com

Contributing Author

Technical and Fundamental Analysis

Experience

Thomas Hughes has been a contributing writer for MarketBeat since 2019.

Areas of Expertise

Technical analysis, the S&P 500; retail, consumer, consumer staples, dividends, high-yield, small caps, technology, economic data, oil, cryptocurrencies

Education

Associate of Arts in Culinary Technology

Past Experience

Market watcher, trader and investor for numerous websites. Founded Passive Market Intelligence LLC to provide market research insights. 


Featured Articles and Offers

Search Headlines: